INS and Cognitive impairment: In general, providers do not recognize the administration of medication as a potential barrier to adherence, except in the case of patients with physical or cognitive impairments [75,82,84], co-morbid conditions [75, 83, 84], or related to treatments, for example fear of needles upon initiation of insulin treatment [20, 82, 84, 86, 110].